Nov 26, 2019Inflection Biosciences Selected as Tech Tour Contest Finalist for 2019Dublin, Ireland, November 26, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, today announced th...
Oct 30, 2019Inflection Biosciences Announces Passing of Co-Founder and Board Member John ScanlanDublin, Ireland, October 30, 2019 – Inflection Biosciences Ltd today announced that John Scanlan, a co-founder and a member of its Board of Directors, passed...
Sep 9, 2019Inflection Biosciences Announces Pre-clinical Data to be Presented at IASLC 2019 World Conference onDublin, Ireland, September 9th, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, today announced ...
Aug 7, 2019Inflection Biosciences Announces Publication of Positive Data for PIM/PI3K/mTOR InhibitorDublin, Ireland, August 7, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, today announced the p...
Jul 18, 2019Inflection Biosciences and AUM Biosciences announce Global License Agreement for PIM/PI3K/mTOR Dublin, Ireland, 18 July 2019 – Inflection Biosciences (Inflection), a company developing innovative therapeutics for the treatment of cancer, and AUM Biosci...
